time meta analysis - Robuta Search

https://c19early.org/bmeta.html Bromhexine for COVID-19: real-time meta-analysis of 7 studies 7 bromhexine COVID-19 controlled studies. 43% improvement, p = 0.072. covid 19 real time meta analysis 7 studies https://c19early.org/naclmeta.html NaCl reduces COVID-19 risk: real-time meta-analysis of 9 studies 9 NaCl COVID-19 controlled studies. 23% improvement, p = 0.0028. reduces covid 19 risk real time meta analysis nacl studies https://c19early.org/ppimeta.html Proton Pump Inhibitors increase COVID-19 risk: real-time meta-analysis of 40 studies covid 19 risk real time meta proton pump inhibitors https://c19early.org/b9meta.html Vitamin B9 for COVID-19: real-time meta-analysis of 18 studies (12 treatment studies and 6... 12 vitamin B9 COVID-19 controlled studies. 8% increased risk, p = 0.6. covid 19 real time meta analysis vitamin b9 18 studies https://c19early.org/rgmeta.html Regdanvimab reduced COVID-19 risk: real-time meta-analysis of 12 studies 12 regdanvimab COVID-19 controlled studies. 54% improvement for early treatment, p = 0.00099. reduced covid 19 risk real time meta analysis 12 studies https://c19early.org/mfmeta.html Metformin reduces COVID-19 risk: real-time meta-analysis of 111 studies reduces covid 19 risk real time meta analysis metformin 111 https://c19early.org/ameta.html Favipiravir for COVID-19: real-time meta-analysis of 74 studies 74 favipiravir COVID-19 controlled studies. 11% improvement, p = 0.0096. covid 19 real time meta analysis favipiravir 74 studies https://c19early.org/lrmeta.html Leritrelvir for COVID-19: real-time meta-analysis of 2 studies 2 leritrelvir COVID-19 controlled studies. 21% improvement, p = 0.022. covid 19 real time meta analysis 2 studies https://c19early.org/vmeta.html Sotrovimab reduced COVID-19 risk: real-time meta-analysis of 29 studies 29 sotrovimab COVID-19 controlled studies. 26% improvement for early treatment, p = 0.00023. reduced covid 19 risk real time meta analysis sotrovimab 29 https://c19early.org/mkmeta.html Montelukast reduces COVID-19 risk: real-time meta-analysis of 9 studies 9 montelukast COVID-19 controlled studies. 39% improvement, p = 0.0041. reduces covid 19 risk real time meta analysis montelukast studies https://c19early.org/h1meta.html Antihistamine H1RAs reduce COVID-19 risk: real-time meta-analysis of 17 studies covid 19 risk real time meta 17 studies antihistamine reduce https://c19early.org/cmeta.html Vitamin C reduces COVID-19 risk: real-time meta-analysis of 72 studies 72 vitamin C COVID-19 controlled studies. 34% improvement for early treatment, p = 0.0082. reduces covid 19 risk real time meta analysis vitamin 72 https://c19early.org/zmeta.html Zinc reduces COVID-19 risk: real-time meta-analysis of 41 studies 41 zinc COVID-19 controlled studies. 41% improvement for early treatment, p = 0.018. reduces covid 19 risk real time meta analysis zinc 41 https://c19early.org/cpcmeta.html Cetylpyridinium Chloride reduces COVID-19 risk: real-time meta-analysis of 4 studies 4 cetylpyridinium chloride COVID-19 controlled studies. 37% improvement for early treatment, p = 0.0042. reduces covid 19 risk real time meta analysis 4 studies chloride https://c19early.org/vameta.html Vitamin A for COVID-19: real-time meta-analysis of 21 studies (14 treatment studies and 7... 14 vitamin A COVID-19 controlled studies. 33% improvement, p = 0.004. covid 19 real time meta analysis 21 studies vitamin 14 https://c19early.org/xmeta.html Proxalutamide reduces COVID-19 risk: real-time meta-analysis of 4 studies reduces covid 19 risk real time meta analysis 4 studies https://c19early.org/rmeta.html Casirivimab/imdevimab reduced COVID-19 risk: real-time meta-analysis of 34 studies reduced covid 19 risk real time meta analysis casirivimab 34 https://c19early.org/dtmeta.html Healthier diets reduce COVID-19 risk: real-time meta-analysis of 30 studies covid 19 risk real time meta healthier diets reduce https://c19early.org/admeta.html Adintrevimab for COVID-19: real-time meta-analysis of 2 studies 2 adintrevimab COVID-19 controlled studies. 43% improvement, p = 0.48. covid 19 real time meta analysis 2 studies https://c19early.org/chxmeta.html Chlorhexidine reduces COVID-19 risk: real-time meta-analysis of 5 studies 5 chlorhexidine COVID-19 controlled studies. 69% improvement for early treatment, p = 0.00063. reduces covid 19 risk real time meta analysis 5 studies chlorhexidine https://c19early.org/tcmeta.html Tixagevimab/cilgavimab reduced COVID-19 risk: real-time meta-analysis of 19 studies 19 tixagevimab/cilgavimab COVID-19 controlled studies. 34% improvement, p = 0.0066. reduced covid 19 risk real time meta analysis studies https://c19early.org/hhmeta.html HH-120 for COVID-19: real-time meta-analysis of 2 studies 2 HH-120 COVID-19 controlled studies. 49% improvement, p = 0.25. covid 19 real time meta analysis hh 120 studies https://c19early.org/evmeta.html Ensovibep for COVID-19: real-time meta-analysis of 2 studies 2 ensovibep COVID-19 controlled studies. 47% improvement, p = 0.37. covid 19 real time meta analysis 2 studies https://c19early.org/gmeta.html Iota-carrageenan for COVID-19: real-time meta-analysis of 1 study 1 iota-carrageenan COVID-19 controlled study. 80% improvement, p = 0.018. covid 19 real time meta analysis iota carrageenan study https://c19early.org/ammeta.html Amubarvimab/romlusevimab for COVID-19: real-time meta-analysis of 4 studies 4 amubarvimab COVID-19 controlled studies. 25% improvement, p = 0.51. covid 19 real time meta analysis 4 studies https://c19early.org/jmeta.html Melatonin reduces COVID-19 risk: real-time meta-analysis of 18 studies reduces covid 19 risk real time meta analysis melatonin 18 https://c19early.org/smeta.html Remdesivir for COVID-19: real-time meta-analysis of 81 studies 81 remdesivir COVID-19 controlled studies. 4% increased risk, p = 0.36. covid 19 real time meta analysis remdesivir 81 studies https://c19early.org/ttmeta.html Thermotherapy reduces COVID-19 risk: real-time meta-analysis of 4 studies 4 thermotherapy COVID-19 controlled studies. 56% improvement, p = 0.026. reduces covid 19 risk real time meta analysis 4 studies https://c19early.org/nacmeta.html N-acetylcysteine reduces COVID-19 risk: real-time meta-analysis of 25 studies reduces covid 19 risk real time meta analysis 25 studies acetylcysteine https://c19early.org/ppmeta.html Propolis for COVID-19: real-time meta-analysis of 3 studies 3 propolis COVID-19 controlled studies. 41% improvement, p = 0.11. covid 19 real time meta analysis 3 studies propolis https://c19early.org/sa58meta.html SA58 reduced COVID-19 risk: real-time meta-analysis of 3 studies 3 SA58 COVID-19 controlled studies. 67% improvement, p = 0.018. reduced covid 19 risk real time meta analysis 3 studies sa58 https://c19early.org/iufhmeta.html Inhaled Heparin reduces COVID-19 risk: real-time meta-analysis of 3 studies 3 inhaled heparin COVID-19 controlled studies. 50% improvement, p = 0.0077. reduces covid 19 risk real time meta analysis 3 studies inhaled https://c19early.org/ometa.html Colchicine reduces COVID-19 risk: real-time meta-analysis of 54 studies reduces covid 19 risk real time meta analysis colchicine 54 https://c19early.org/phmeta.html Alkalinization reduces COVID-19 risk: real-time meta-analysis of 14 studies reduces covid 19 risk real time meta analysis 14 studies https://c19early.org/vvmeta.html Deuremidevir for COVID-19: real-time meta-analysis of 2 studies 2 deuremidevir COVID-19 controlled studies. 11% improvement, p = 0.062. covid 19 real time meta analysis 2 studies https://c19early.org/pmeta.html Povidone-Iodine reduces COVID-19 risk: real-time meta-analysis of 21 studies reduces covid 19 risk real time povidone iodine meta analysis 21 studies https://c19early.org/tmeta.html Curcumin reduces COVID-19 risk: real-time meta-analysis of 28 studies 28 curcumin COVID-19 controlled studies. 29% improvement for early treatment, p = 0.0014. reduces covid 19 risk real time meta analysis curcumin 28 https://c19early.org/imeta.html Ivermectin reduces COVID-19 risk: real-time meta-analysis of 106 studies (c19ivm ivmmeta) reduces covid 19 risk real time meta analysis ivermectin 106 https://c19early.org/ibmeta.html Ibuprofen for COVID-19: real-time meta-analysis of 13 studies 13 ibuprofen COVID-19 controlled studies. 0% improvement, p = 0.96. covid 19 real time meta analysis ibuprofen 13 studies https://c19early.org/gmmeta.html Sargramostim for COVID-19: real-time meta-analysis of 4 studies 4 sargramostim COVID-19 controlled studies. 13% increased risk, p = 0.64. covid 19 real time meta analysis 4 studies https://c19early.org/azvmeta.html Azvudine reduces COVID-19 risk: real-time meta-analysis of 42 studies 42 azvudine COVID-19 controlled studies. 32% improvement for early treatment, p = 0.032. reduces covid 19 risk real time meta analysis 42 studies https://c19early.org/udcameta.html Ursodeoxycholic acid for COVID-19: real-time meta-analysis of 22 studies 22 ursodeoxycholic acid COVID-19 controlled studies. 18% improvement, p = 0.092. covid 19 real time meta analysis acid 22 studies